SIPORE
Live / Registered — Registered (as of 03 Mar 2020)
What this means for you
Registered since 03 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79245402
- Registration number
- 5999045
- Mark type
- Stylized text
- Filed
- 01 Jun 2018
- Published for opposition
- 17 Dec 2019
- Registered
- 03 Mar 2020
- Attorney of record
- Bradley L. Cohn
Goods and services
- Class 005 — Pharmaceuticals: Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
- Class 010 — Medical apparatus: Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
Owner
Prosecution history
- 18 Apr 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 03 Mar 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 02 Apr 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Jul 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 08 Jul 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 08 Jul 2020 — FINAL DISPOSITION PROCESSED
- 03 Jun 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 20 Dec 2019 — NOTIFICATION PROCESSED BY IB
- 17 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2019 — PUBLISHED FOR OPPOSITION
- 04 Dec 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Dec 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED